MOLN Q4 2025 Earnings Positive EPS Surprise Highlights Cost Discipline Amid Clinical Progress ISRG Q1 2026 Earnings EPS Beat by 168 Amid Revenue Discrepancy VMD Q1 2026 Earnings EPS Misses Estimates by 34 Amid Uncertain Revenue Outlook National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Sees Slight Decline KALA Q4 2025 Earnings Loss Narrows Sharply on Disciplined Cost Management WFC Q1 2026 Earnings Modest EPS Beat Amidst Stable Performance